JP2014508174A5 - - Google Patents

Download PDF

Info

Publication number
JP2014508174A5
JP2014508174A5 JP2013558168A JP2013558168A JP2014508174A5 JP 2014508174 A5 JP2014508174 A5 JP 2014508174A5 JP 2013558168 A JP2013558168 A JP 2013558168A JP 2013558168 A JP2013558168 A JP 2013558168A JP 2014508174 A5 JP2014508174 A5 JP 2014508174A5
Authority
JP
Japan
Prior art keywords
dose
dose adjustment
week
interferon
adjustment package
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013558168A
Other languages
English (en)
Japanese (ja)
Other versions
JP6279905B2 (ja
JP2014508174A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/029201 external-priority patent/WO2012125809A1/en
Publication of JP2014508174A publication Critical patent/JP2014508174A/ja
Publication of JP2014508174A5 publication Critical patent/JP2014508174A5/ja
Application granted granted Critical
Publication of JP6279905B2 publication Critical patent/JP6279905B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013558168A 2011-03-15 2012-03-15 速い用量調節の漸増投与レジメンを用いた、インターフェロンの筋肉内投与に伴うインフルエンザ様症状を軽減するための方法 Active JP6279905B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201161452807P 2011-03-15 2011-03-15
US61/452,807 2011-03-15
US201161476930P 2011-04-19 2011-04-19
US61/476,930 2011-04-19
PCT/US2012/029201 WO2012125809A1 (en) 2011-03-15 2012-03-15 Method for reducing flu-like symptoms associated with intramuscular administration of interferon using a fast titration escalating dosing regimen

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017170640A Division JP6522069B2 (ja) 2011-03-15 2017-09-05 速い用量調節の漸増投与レジメンを用いた、インターフェロンの筋肉内投与に伴うインフルエンザ様症状を軽減するための方法

Publications (3)

Publication Number Publication Date
JP2014508174A JP2014508174A (ja) 2014-04-03
JP2014508174A5 true JP2014508174A5 (https=) 2015-04-16
JP6279905B2 JP6279905B2 (ja) 2018-02-14

Family

ID=46045072

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2013558168A Active JP6279905B2 (ja) 2011-03-15 2012-03-15 速い用量調節の漸増投与レジメンを用いた、インターフェロンの筋肉内投与に伴うインフルエンザ様症状を軽減するための方法
JP2017170640A Active JP6522069B2 (ja) 2011-03-15 2017-09-05 速い用量調節の漸増投与レジメンを用いた、インターフェロンの筋肉内投与に伴うインフルエンザ様症状を軽減するための方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2017170640A Active JP6522069B2 (ja) 2011-03-15 2017-09-05 速い用量調節の漸増投与レジメンを用いた、インターフェロンの筋肉内投与に伴うインフルエンザ様症状を軽減するための方法

Country Status (25)

Country Link
US (6) US9198955B2 (https=)
EP (1) EP2686002B1 (https=)
JP (2) JP6279905B2 (https=)
KR (1) KR102050339B1 (https=)
CN (1) CN103702680A (https=)
AU (1) AU2012229104B2 (https=)
BR (1) BR112013023609A8 (https=)
CA (1) CA2846786C (https=)
CY (1) CY1120176T1 (https=)
DK (1) DK2686002T3 (https=)
EA (1) EA028448B1 (https=)
ES (1) ES2666850T3 (https=)
HR (1) HRP20180621T1 (https=)
HU (1) HUE036931T2 (https=)
IL (1) IL228425A (https=)
LT (1) LT2686002T (https=)
MX (1) MX359947B (https=)
PL (1) PL2686002T3 (https=)
PT (1) PT2686002T (https=)
RS (1) RS57175B1 (https=)
SG (1) SG193446A1 (https=)
SI (1) SI2686002T1 (https=)
SM (1) SMT201800221T1 (https=)
WO (1) WO2012125809A1 (https=)
ZA (1) ZA201306933B (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2686002B1 (en) * 2011-03-15 2018-01-24 Biogen Inc. Method for reducing flu-like symptoms associated with intramuscular administration of interferon using a fast titration escalating dosing regimen
EP3092305B1 (en) * 2014-01-09 2023-08-02 Kyushu University, National University Corporation Method of producing microglial cells
US11266344B2 (en) 2016-09-21 2022-03-08 Samsung Electronics Co., Ltd. Method for measuring skin condition and electronic device therefor
WO2022069250A1 (en) * 2020-09-30 2022-04-07 Koninklijke Philips N.V. Methods and systems for performing dose titration

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4456748A (en) 1981-02-23 1984-06-26 Genentech, Inc. Hybrid human leukocyte interferons
DE3273787D1 (en) 1981-02-04 1986-11-20 Japan Found Cancer Human interferon-beta gene
US4695543A (en) 1982-03-23 1987-09-22 Bristol-Myers Company Alpha Interferon GX-1
CA1302320C (en) 1984-06-11 1992-06-02 Hideo Niwa Expression of human cromosomal interferon-_ in animal cells
US5231176A (en) 1984-08-27 1993-07-27 Genentech, Inc. Distinct family DNA encoding of human leukocyte interferons
FI90990C (fi) 1984-12-18 1994-04-25 Boehringer Ingelheim Int Rekombinantti-DNA-molekyyli, transformoitu isäntäorganismi ja menetelmä interferonin valmistamiseksi
EP0205404B1 (en) 1985-06-11 1992-07-15 Ciba-Geigy Ag Hybrid interferons
US5641656A (en) 1993-10-22 1997-06-24 University Of Connecticut Nucleic acids encoding avian interferon (IFN) proteins and recombinant methods using them
TR199901968T2 (xx) * 1996-12-24 1999-12-21 Biogen, Inc. Sabit s�v� interferon form�lleri.
JP2001104482A (ja) * 1999-10-07 2001-04-17 Terumo Corp 2室型プレフィルドシリンジ
EP1605992B1 (en) * 2003-01-30 2018-11-21 Becton, Dickinson and Company Holder with safety shield for a drug delivery device
JP4988562B2 (ja) * 2004-06-01 2012-08-01 アレス トレーディング ソシエテ アノニム 安定化したインターフェロン液体製剤
US20060089593A1 (en) * 2004-10-26 2006-04-27 Sergio Landau Needle-free injection device for individual users
EP1923085A1 (en) * 2006-11-17 2008-05-21 Sanofi-Aventis Deutschland GmbH Dosing and drive mechanism for drug delivery device
CA2672284C (en) * 2006-12-18 2014-08-26 Altus Pharmaceuticals Inc. Human growth hormone formulations
US9044378B2 (en) * 2007-05-31 2015-06-02 Safety Syringes, Inc. Anti-needle stick safety device or system for use with drugs requiring reconstitution
JP5549048B2 (ja) * 2007-08-16 2014-07-16 味の素株式会社 薬剤バイアルとプレフィルドシリンジの接続構造
JP2012530721A (ja) * 2009-06-18 2012-12-06 ワイス・エルエルシー 小モジュール免疫薬のための凍結乾燥製剤
EP2686002B1 (en) * 2011-03-15 2018-01-24 Biogen Inc. Method for reducing flu-like symptoms associated with intramuscular administration of interferon using a fast titration escalating dosing regimen

Similar Documents

Publication Publication Date Title
Zhang et al. Just how prevalent are peptide therapeutic products? A critical review
JP2015187125A5 (https=)
Middleton et al. Complications of injectable testosterone undecanoate in routine clinical practice
HRP20170056T2 (hr) Terapija male učestalosti glatiramer acetatom
JP2018510898A5 (https=)
JP2018514534A5 (https=)
NZ599558A (en) Dosing regimen associated with long-acting injectable paliperidone esters
IL309340A (en) Dosing regimen for missing doses of paliperidone long-acting injectable esters
RU2008138381A (ru) Режимы дозирования адреналина
Cutolo et al. Efficacy of the switch to modified-release prednisone in rheumatoid arthritis patients treated with standard glucocorticoids
JP2018510894A5 (https=)
JP2016526039A5 (https=)
RU2015152860A (ru) Режим введения и составы для аденовирусов типа в
JP2014508174A5 (https=)
JP2016534996A5 (https=)
JP2019511506A5 (https=)
HRP20201388T1 (hr) Režimi i postupci liječenja multiple skleroze uporabom ofatumumaba
Gopalakrishna et al. Long-acting injectable aripiprazole: how might it fit in our tool box?
JP2016515137A5 (https=)
HRP20240812T1 (hr) Oblici doziranja i terapijska primjena l-4-klorokinurenina
JP2014520874A5 (https=)
MX2018005298A (es) Regimen de dosificacion para un inhibidor de fosfatidilinositol 3-quinasa.
SI2686002T1 (en) A method for reducing influenza-like symptoms associated with intramuscular delivery of interferon by the rapid titration-enhancing regimen
JP2023020885A5 (https=)
Baweja et al. Long-acting antipsychotic medications